Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Icosapent manufacturers

5 products found

Filters

5 products found
The only dossier on the platform

icosapent

Capsules 1 g

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Generic equivalent to Vazkepa/Vascepa.Daily dose - 4 g
Manufacturer #30786

This company specializes in developing and supplying innovative prescription medications, particularly in the areas of cardiology and diabetes. They boast a global presence with products available in over 35 countries, including major markets in Europe, Asia, Latin America, and Africa. Their focus on combination medicines and strong R&D capabilities allow them to provide cost-effective solutions for patient health. With a decade-plus of experience, they have built a network of manufacturing sites that meet EU and other international GMP standards. While specific product patents were not found on their website, their commitment to innovation in these crucial therapeutic areas suggests a dedication to ongoing research and development.

The only dossier on the platform

icosapent + atorvastatin

Capsules 4 g + 40 mg, 4 g + 20 mg, 4 g + 10 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Form: TBD
Manufacturer #30786

This company specializes in developing and supplying innovative prescription medications, particularly in the areas of cardiology and diabetes. They boast a global presence with products available in over 35 countries, including major markets in Europe, Asia, Latin America, and Africa. Their focus on combination medicines and strong R&D capabilities allow them to provide cost-effective solutions for patient health. With a decade-plus of experience, they have built a network of manufacturing sites that meet EU and other international GMP standards. While specific product patents were not found on their website, their commitment to innovation in these crucial therapeutic areas suggests a dedication to ongoing research and development.

The only dossier on the platform

icosapent + rosuvastatin + ezetimibe

Capsules 4 g + 40 mg + 10 mg, 4 g + 20 mg + 10 mg, 4 g + 10 mg + 10 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Form: TBD
Manufacturer #30786

This company specializes in developing and supplying innovative prescription medications, particularly in the areas of cardiology and diabetes. They boast a global presence with products available in over 35 countries, including major markets in Europe, Asia, Latin America, and Africa. Their focus on combination medicines and strong R&D capabilities allow them to provide cost-effective solutions for patient health. With a decade-plus of experience, they have built a network of manufacturing sites that meet EU and other international GMP standards. While specific product patents were not found on their website, their commitment to innovation in these crucial therapeutic areas suggests a dedication to ongoing research and development.

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible